Abstract
Carbon monoxide (CO), like nitric oxide (NO), has been reported to have biologic actions such as smooth muscle relaxation1 or inhibition of platelet aggregation,2 and to act as a neural messenger in the brain.3,4 CO is produced endogenously in many tissues of the body by the class of enzymes known collectively as heme oxygenase (HO).5 Two forms of HO have been characterized. Of these, HO-1 is present in the pulmonary vascular endothelium,6 alveolar macrophages7 and human airway epithelium,8 and is induced by oxidative stress,6,9 inflammatory cytokines,10,11 and NO.12 HO-2 is not inducible and is widely distributed throughout the body, with high concentrations in the brain.5 CO can be detected in exhaled air in smokers and non-smokers.13 The pathogenesis of inflammatory respiratory diseases is associated with several factors including oxidative stress and inflammatory cytokines. Therefore, we studied whether the levels of exhaled CO increase in patients with inflammatory respiratory diseases.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
M. Suematsu, N. Goda, T. Sano, S. Kashiwagi, T. Egawa, Y. Shinoda, and Y. Ishimura, Carbon monoxide, an endogenous modulator of sinusoidal tone in the perfused rat liver, J Clin Invest 96:2431–2437(1995).
B. Brune and J. Ullrich, Inhibition of platelet aggregation by carbon monoxide is mediated by activation of guanylate cyclase, Mol Pharmacol 32:497–504 (1987).
A. Verma, D.J. Hirsch, C.E. Glatt, and G.V. Ronnett, and S.H. Snyder, Carbon monoxide: a putative neural messenger, Science 259:381–384 (1993).
M. Zhuo, S.A. Small, E.R. Kandel, and R.D. Hawkins, Nitric oxide and carbon monoxide produce activity-dependent long-term synaptic enhancement in hippocampus, Science 260:1946–1950 (1993).
M.D. Maines, Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical applications, FASEB J 2:2557–2568 (1988).
L. Otterbein, S.L. Sylvester, and A.M.K. Choi, Hemoglobin provides protection against lethal endotoxin in rats: the role of heme oxygenase-1, Am J Respir Cell Mol Biol 13:595–601 (1995).
T. Fukushima, S. Okinaga, K. Sekizawa, T. Ohrui, M. Yamaya, and H. Sasaki, The role of carbon monoxide in lucigenin-dependent chemiluminescence of rat alveolar macrophages, Eur J Pharmacol 289:103–107 (1995).
N. Yamada, M. Yamaya, S. Okinaga, R. Lie, T. Suzuki, K. Nakayama, A. Takeda, T. Yamaguchi, Y. Itoyama, K. Sekizawa, and H. Sasaki, Protective effects of heme oxygenase-1 against oxidant-induced injury in the cultured human tracheal epithelium. Am J Respir Cell Mol Biol 21:428–435 (1999).
S.L. Camhi, J. Alam, L. Otterbein, S.L. Sylvester, and A.M.K. Choi, Induction of heme oxygenase-1 gene expression by lipopolysaccharide is mediated by AP-1 activation, Am J Respir Cell Mol Biol 13:387–398 (1995).
L. Cantoni, C. Rossi, M. Rizzardini, M. Gardina, and P. Ghezzi, Interleukin-1 and tunor necrosis factor induce hepatic heme oxygenase: feedback regulation by glucocorticoids, Biochem J 279: 891–94 (1991).
Y. Lavrovsky, G.S. Drummond, and N.G. Abraham, Downregulation of the human heme oxygenase gene by glucocorticoids and identification of 56b regulatory elements, Biochem Biophys Res Commun 218:759–765 (1996).
Y.M. Kim, H.A. Bergonia, C. Muller, B.R. Pitt, W.D. Watkins, and J.R. Lancaster, Loss and degradation of enzyme-bound heme induced by cellular nitric oxide synthesis, J Biol Chem 270:5710–5713 (1995).
M.J. Jarvis, M. Belcher, C. Vesey, and D.C.S. Hutchison, Low cost carbon monoxide monitors in smoking assessment, Thorax 41:886–887 (1986).
P.J. Barnes, Anti-inflammatory therapy for asthma, Annu Rev Med 44;229–242 (1993).
A.L. Sheffer, International consensus report on the diagnosis and management of asthma, Clin Exp Allergy 22:1–72 (1992).
K. Zayasu, K. Sekizawa, S. Okinaga, M. Yamaya, T. Ohrui, and H. Sasaki, Increased carbon monoxide in exhaled air of asthmatic patients, Am J Respir Crit Care Med 156:1140–1143 (1997).
M. Yamaya, K. Sekizawa, S. Ishizuka, M. Monma, and H. Sasaki, Exhaled carbon monoxide levels during treatment of acute asthma, Eur Respir J 13:757–760 (1999).
S.A. Kharitonov, D. Yates, and P.J. Barnes, Increased nitric oxide in exhaled air of normal human subjects with upper respiratory tract infections, Eur Respir J 8:295–297 (1995).
P.M. O’Byrne, and D.S. Postma, The many faces of airway inflammation. Asthma and chronic obstructive pulmonary disease, Am J Respir Crit Care Med 159:S41–S66 (1999).
R. Djukanovic, W.R. Roche, J.W. Wilson, C.R.W. Beasley, O.P. Twentyman, P.H. Howarth, and S.T. Holgate, Mucosal inflammation in asthma, Am Rev Respir Dis 142:434–457 (1990).
J. Bousquet, P. Chanez, J.Y. Lacoste, G. Barneon, N. Ghavanian, I. Enander, P. Venge, S. Ahlstedt, J. Simony-Lafontaine, and P. Godard, Eosinophilic inflammation in asthma, N Engl J Med 323: 1033–1039 (1990).
M. Yamaya, M. Hosoda, S. Ishizuka, M. Monma, T. Matsui, T. Suzuki, K. Sekizawa, and H. Sasaki, Relation between exhaled carbon monoxide levels and clinical severity of asthma, Clin Exp Allergy 31:417–722 (2001).
P.D. Pare and T.R. Bai, The consequences of chronic allergic inflammation, Thorax 50:328–332 (1995).
N. Carroll, J. Elliot, A. Morton, and A. James A, The structure of large and small airways in non-fatal and fatal asthma, Am Rev Resspir Dis 147:405–410 (1993).
L.C.K. Lau, J.M. Corne, S.J. Scott, R. Davies, E. Friend, and PH. Howarth, Nasal cytokines in common cold (abstract), Am J Respir Crit Care Med l53:A697 (1996).
M. Yamaya, K. Sekizawa, S. Ishizuka, M. Monma, K. Mizuta, and H. Sasaki H, Increased carbon monoxide in exhaled air of subjects with upper respiratory tract infections, Am J Respir Crit Care Med 158:311–314 (1998).
G.G. Jackson, H.F. Dowling, I.G Spiesman, and A.V. Boand, Transmission of the common cold to volunteers under controlled conditions: I. The common cold as a clinical entity, Arch Intern Med 101:267–278 (1958).
Y. Igarashi, M.S. Goldrich, M.A. Kaliner, A.M.A. Irani, L.B. Schwartz, and M.V. White, Quantitation of inflammatory cells in the nasal mucosa of patients with allergic rhinitis and normal sub- jects. J Allergy Clin Immunol 95:716–725 (1995).
S. Ying, S.R. Durham, J. Barkans, K. Masuyama, M. Jacobson, S. Rak, O. Lowhagen, R. Moqbel, A.B. Kay, and Q.A. Hamid, T cells are the principal source of interleukin-5 mRNA in allergen-induced rhinitis, Am J Respir Cell Mol Biol 9:356–360 (1993).
T.C. Sim, L.M. Reece, K.A. Hilsmeier, J.A. Grant, and R. Alam, Secretion of chemokines and other cytokines in allergen-induced nasal responses: Inhibition by topical steroid treatment. Am J Respir Crit Care Med 152:927–933 (1995).
M. Monma, M. Yamaya, K. Sekizawa, K. Ikeda, N. Suzuki, T. Kikuchi, T. Takasaka, and H. Sasaki, Increased carbon monoxide in exhaled air of patients with seasonal allergic rhinitis, Clin Exp Allergy 29:1537–1541 (1999).
J. Day and T. Carrillo, Comparison of the efficacy of budesonide and fluticasone propionate aqueous nasal spray for once daily treatment of perennial allergic rhinitis, J Allergy Clin Immunol 102:902–908 (1998).
J.F. Arnal, A. Didier, J. Rami, C. M’Rini, J.R Charlet, E. Serrano, and J.P. Besombes, Nasal nitric oxide is increased in allergic rhinitis, Clin Exp Allergy 27:358–362 (1997).
P.E. Silkoff, P.A. McClean, A.S. Slutsky, H.G. Furlott, E. Hoffstein, S. Wakita, K.R. Chapman, J.P. Szalai, and N. Zamel, Marked flow-dependence of exhaled nitric oxide using a new technique to exclude nasal nitic oxide, Am J Respir Crit Care Med 155:260–267 (1997).
P.H. Howarth, J. Wilson, R. Djukanovic, S. Wilson, K. Britten, A. Walls, W.R. Roche, and S.T. Holgate, Airway inflammation and atopic asthma: a comparative bronchoscopic investigation. Int Arch Allergy Appl Immunol 94:266–269 (1991).
J. Chakir, M. Laviolette, M. Boutet, R. Laliberte, J. Dube, and L.P. Boulet, Lower airways remodeling in nonasthmatic subjects with allergic rhinitis, Lab Invest 75:735–744 (1996).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer Science+Business Media New York
About this chapter
Cite this chapter
Yamaya, M., Okinaga, S., Sekizawa, K., Monma, M., Sasaki, H. (2002). Increased Carbon Monoxide in Exhaled Air in Patients with Inflammatory Respiratory Diseases. In: Abraham, N.G. (eds) Heme Oxygenase in Biology and Medicine. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-0741-3_7
Download citation
DOI: https://doi.org/10.1007/978-1-4615-0741-3_7
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5219-8
Online ISBN: 978-1-4615-0741-3
eBook Packages: Springer Book Archive